Spain is the first country to receive doses of BIMERVAX® after its approval on March 30
On Friday, April 28, the biotechnical pharmaceutical company HIPRA delivered the first doses of BIMERVAX®, its vaccine against COVID-19, one month after receiving approval from the European Medicines Agency (EMA) and the European Commission for its commercialization in Europe.
The first country to have the new recombinant protein vaccine has been Spain, which has acquired 3.2 million doses, as announced by the President of the Government, Pedro Sánchez, during his visit to HIPRA in mid-April.